We are live on ! Find out more
JJBC

James J. Burns & Company Portfolio holdings

AUM $924M
1-Year Est. Return 22.18%
This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+22.18%
3 Year Est. Return
+63.12%
5 Year Est. Return
10 Year Est. Return
AUM
$420M
AUM Growth
+$47.5M
Cap. Flow
+$9.09M
Cap. Flow %
2.16%
Top 10 Hldgs %
62.21%
Holding
122
New
18
Increased
52
Reduced
43
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 4.35%
2 Financials 1.48%
3 Consumer Discretionary 1.46%
4 Communication Services 1.4%
5 Healthcare 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
101
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$267K 0.06%
2,993
-69
-2% -$5.12K
NVDA icon
102
NVIDIA
NVDA
$5.42T
$260K 0.06%
5,270
+210
+4% +$9.73K
DIS icon
103
Walt Disney
DIS
$181B
$251K 0.06%
2,772
-14
-0.5% -$1.23K
JMST icon
104
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.15B
$250K 0.06%
4,932
+19
+0.4% +$961
SHW icon
105
Sherwin-Williams
SHW
$89.8B
$250K 0.06%
800
TECL icon
106
Direxion Daily Technology Bull 3x ETF
TECL
$6.21B
$248K 0.06%
+3,725
New +$202K
USMV icon
107
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
$244K 0.06%
3,133
-125
-4% -$9.33K
MRNA icon
108
Moderna
MRNA
$23.6B
$241K 0.06%
+2,425
New +$204K
ADBE icon
109
Adobe
ADBE
$105B
$231K 0.06%
+388
New +$224K
QLD icon
110
ProShares Ultra QQQ
QLD
$14.1B
$229K 0.05%
+6,034
New +$199K
QQQ icon
111
Invesco QQQ Trust
QQQ
$481B
$229K 0.05%
+561
New +$213K
ABBV icon
112
AbbVie
ABBV
$435B
$219K 0.05%
1,413
-213
-13% -$31.1K
IT icon
113
Gartner
IT
$11.7B
$217K 0.05%
+480
New +$192K
GNOM icon
114
Global X Genomics & Biotechnology ETF
GNOM
$85.2M
$214K 0.05%
4,620
+1,212
+36% +$49.4K
AXP icon
115
American Express
AXP
$230B
$213K 0.05%
+1,135
New +$183K
ORCL icon
116
Oracle
ORCL
$423B
$213K 0.05%
2,025
CLOU icon
117
Global X Cloud Computing ETF
CLOU
$263M
$208K 0.05%
+9,152
New +$182K
VUG icon
118
Vanguard Morningstar Growth ETF
VUG
$230B
$208K 0.05%
+3,996
New +$193K
F icon
119
Ford
F
$55.7B
$163K 0.04%
13,429
-3,154
-19% -$35.1K
AKBA icon
120
Akebia Therapeutics
AKBA
$252M
$23K 0.01%
18,402
-6,140
-25% -$6.26K
SCHD icon
121
Schwab US Dividend Equity ETF
SCHD
$106B
-1,218,621
Closed -$28.7M
SEDG icon
122
SolarEdge
SEDG
$1.95B
-2,600
Closed -$337K

Similar funds

James J. Burns & Company's Q4 2023 Portfolio in Review

As of Q4 2023, James J. Burns & Company held 122 positions worth $420M, up 13% from $372M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

James J. Burns & Company's Q4 2023 filing shows 18 new, 52 increased, 43 reduced and 2 closed positions. Its largest new stake was Eli Lilly: 2,000 shares worth $1.17M. The largest sale was Schwab US Dividend Equity ETF, an estimated $28.7M.

By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 4.6% a quarter earlier, followed by Financials and Consumer Discretionary.

  • James J. Burns & Company's largest Q4 2023 buy was Eli Lilly: 2,000 shares worth $1.17M.
  • James J. Burns & Company added most to Vanguard Morningstar Large-Cap ETF in Q4 2023, an estimated $26.6M increase.
  • James J. Burns & Company's biggest Q4 2023 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $3.12M.
  • James J. Burns & Company fully exited Schwab US Dividend Equity ETF in Q4 2023, selling an estimated $28.7M.
  • James J. Burns & Company's ten largest holdings make up 62% of its $420M portfolio in Q4 2023.
  • James J. Burns & Company opened 18 new positions and closed 2 in Q4 2023.
  • James J. Burns & Company's portfolio value rose 13% quarter-over-quarter to $420M.

Based on James J. Burns & Company's 13F filing for Q4 2023, filed 13 Feb 2024.